145 related articles for article (PubMed ID: 18347935)
1. The diagnostic value of macrophage migration inhibitory factor (MIF) in gastric cancer.
Camlica H; Duranyildiz D; Oguz H; Oral EN; Yasasever V
Pathol Oncol Res; 2008 Mar; 14(1):79-83. PubMed ID: 18347935
[TBL] [Abstract][Full Text] [Related]
2. Serum macrophage migration-inhibitory factor as a diagnostic and prognostic biomarker for gastric cancer.
Xia HH; Yang Y; Chu KM; Gu Q; Zhang YY; He H; Wong WM; Leung SY; Yuen ST; Yuen MF; Chan AO; Wong BC
Cancer; 2009 Dec; 115(23):5441-9. PubMed ID: 19685530
[TBL] [Abstract][Full Text] [Related]
3. Macrophage migration inhibitory factor in cancer.
Yasasever V; Camlica H; Duranyildiz D; Oguz H; Tas F; Dalay N
Cancer Invest; 2007 Dec; 25(8):715-9. PubMed ID: 18058468
[TBL] [Abstract][Full Text] [Related]
4. Combination of Plasma MIF and VCA-IgA Improves the Diagnostic Specificity for Patients With Nasopharyngeal Carcinoma.
Xue N; Xing S; Ma W; Sheng J; Huang Z; Xu Q
Technol Cancer Res Treat; 2020; 19():1533033820935773. PubMed ID: 32578505
[TBL] [Abstract][Full Text] [Related]
5. Comparison between clinical significance of serum proinflammatory proteins (IL-6 and CRP) and classic tumor markers (CEA and CA 19-9) in gastric cancer.
Lukaszewicz-Zając M; Mroczko B; Gryko M; Kędra B; Szmitkowski M
Clin Exp Med; 2011 Jun; 11(2):89-96. PubMed ID: 20938721
[TBL] [Abstract][Full Text] [Related]
6. MIF reflects tissue damage rather than inflammation in post-cardiac arrest syndrome in a real life cohort.
Pohl J; Rammos C; Totzeck M; Stock P; Kelm M; Rassaf T; Luedike P
Resuscitation; 2016 Mar; 100():32-7. PubMed ID: 26784134
[TBL] [Abstract][Full Text] [Related]
7. Elevated MIF-2 levels predict mortality in critically ill patients.
Pohl J; Hendgen-Cotta UB; Stock P; Luedike P; Rassaf T
J Crit Care; 2017 Aug; 40():52-57. PubMed ID: 28329734
[TBL] [Abstract][Full Text] [Related]
8. Increased serum levels and promoter polymorphisms of macrophage migration inhibitory factor in schizophrenia.
Okazaki S; Hishimoto A; Otsuka I; Watanabe Y; Numata S; Boku S; Shimmyo N; Kinoshita M; Inoue E; Ohmori T; Someya T; Sora I
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr; 83():33-41. PubMed ID: 29305329
[TBL] [Abstract][Full Text] [Related]
9. Increased epithelial and serum expression of macrophage migration inhibitory factor (MIF) in gastric cancer: potential role of MIF in gastric carcinogenesis.
He XX; Yang J; Ding YW; Liu W; Shen QY; Xia HH
Gut; 2006 Jun; 55(6):797-802. PubMed ID: 16488898
[TBL] [Abstract][Full Text] [Related]
10. Macrophage Migration Inhibitory Factor Predicts Outcome in Complex Aortic Surgery.
Gombert A; Stoppe C; Foldenauer AC; Schuerholz T; Martin L; Kalder J; Schälte G; Marx G; Jacobs M; Grommes J
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29120365
[TBL] [Abstract][Full Text] [Related]
11. Predictive potential of macrophage migration inhibitory factor (MIF) in patients with heart failure with preserved ejection fraction (HFpEF).
Luedike P; Alatzides G; Papathanasiou M; Heisler M; Pohl J; Lehmann N; Rassaf T
Eur J Med Res; 2018 May; 23(1):22. PubMed ID: 29728137
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Serum Macrophage Migration Inhibitory Factor (MIF) as an Early Diagnostic Marker of Leptospirosis.
Sumaiya K; Akino Mercy CS; Muralitharan G; Hajinur Hirad A; Alarfaj AA; Natarajaseenivasan K
Front Cell Infect Microbiol; 2021; 11():781476. PubMed ID: 35237527
[TBL] [Abstract][Full Text] [Related]
13. Serum macrophage migration inhibitory factor levels are associated with angiographically complex coronary lesions in patients with coronary artery disease.
Hao Y; Yi SL; Zhong JQ
Genet Test Mol Biomarkers; 2015 Oct; 19(10):556-60. PubMed ID: 26263432
[TBL] [Abstract][Full Text] [Related]
14. Serum levels, tissue expression and cellular secretion of macrophage migration inhibitory factor in limited and diffuse systemic sclerosis.
Corallo C; Paulesu L; Cutolo M; Ietta F; Carotenuto C; Mannelli C; Romagnoli R; Nuti R; Giordano N
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S98-105. PubMed ID: 26005773
[TBL] [Abstract][Full Text] [Related]
15. Serum level of macrophage migration inhibitory factor (MIF) in Egyptians with alopecia areata and its relation to the clinical severity of the disease.
Younan DN; Agamia N; Elshafei A; Ebeid N
J Clin Lab Anal; 2015 Jan; 29(1):74-9. PubMed ID: 24687398
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the relationship between macrophage migration inhibitory factor level and clinical course in patients with COVID-19 pneumonia.
Aksakal A; Kerget B; Kerget F; Aşkın S
J Med Virol; 2021 Dec; 93(12):6519-6524. PubMed ID: 34241898
[TBL] [Abstract][Full Text] [Related]
17. Significance of the vascular endothelial growth factor and the macrophage migration inhibitory factor in the progression of hepatocellular carcinoma.
Wang D; Luo L; Chen W; Chen LZ; Zeng WT; Li W; Huang XH
Oncol Rep; 2014 Mar; 31(3):1199-204. PubMed ID: 24366206
[TBL] [Abstract][Full Text] [Related]
18. A prognostic value of CA 19-9 but not of CEA in patients with gastric cancer.
Victorzon M; Haglund C; Lundin J; Roberts PJ
Eur J Surg Oncol; 1995 Aug; 21(4):379-84. PubMed ID: 7664902
[TBL] [Abstract][Full Text] [Related]
19. Macrophage migration inhibitory factor as a potential prognostic factor in gastric cancer.
He LJ; Xie D; Hu PJ; Liao YJ; Deng HX; Kung HF; Zhu SL
World J Gastroenterol; 2015 Sep; 21(34):9916-26. PubMed ID: 26379396
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of prothrombin induced by vitamin K absence, macrophage migration inhibitory factor and Golgi protein-73 versus alpha fetoprotein for hepatocellular carcinoma diagnosis and surveillance.
Ismail MM; Morsi HK; Abdulateef NA; Noaman MK; Abou El-Ella GA
Scand J Clin Lab Invest; 2017 May; 77(3):175-183. PubMed ID: 28276727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
